UBS AM’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-232,815
| Closed | -$19.8M | – | 2574 |
|
|
2019
Q4 | $19.8M | Sell |
232,815
-99,014
| -30% | -$6.6M | 0.01% | 781 |
|
|
2019
Q3 | $16.6M | Buy |
331,829
+51,598
| +18% | +$2.06M | 0.01% | 812 |
|
|
2019
Q2 | $10.2M | Sell |
280,231
-8,328
| -3% | -$272K | 0.01% | 951 |
|
|
2019
Q1 | $8.07M | Sell |
288,559
-564
| -0.2% | -$13.3K | 0.01% | 990 |
|
|
2018
Q4 | $5.53M | Buy |
289,123
+10,853
| +4% | +$252K | ﹤0.01% | 1061 |
|
|
2018
Q3 | $8.32M | Sell |
278,270
-287,306
| -51% | -$10.8M | 0.01% | 977 |
|
|
2018
Q2 | $20.8M | Sell |
565,576
-4,561
| -0.8% | -$148K | 0.02% | 759 |
|
|
2018
Q1 | $18.8M | Sell |
570,137
-27,055
| -5% | -$845K | 0.01% | 775 |
|
|
2017
Q4 | $16.3M | Sell |
597,192
-296,186
| -33% | -$9.12M | 0.01% | 794 |
|
|
2017
Q3 | $33.1M | Sell |
893,378
-82,638
| -8% | -$3.05M | 0.03% | 571 |
|
|
2017
Q2 | $37.1M | Sell |
976,016
-104,797
| -10% | -$4.67M | 0.04% | 510 |
|
|
2017
Q1 | $52.9M | Sell |
1,080,813
-468,424
| -30% | -$21.4M | 0.05% | 380 |
|
|
2016
Q4 | $52.6M | Sell |
1,549,237
-255,665
| -14% | -$9.07M | 0.06% | 359 |
|
|
2016
Q3 | $68.1M | Sell |
1,804,902
-134,058
| -7% | -$5.05M | 0.07% | 292 |
|
|
2016
Q2 | $65.2M | Sell |
1,938,960
-114,224
| -6% | -$4.03M | 0.07% | 289 |
|
|
2016
Q1 | $65.2M | Buy |
2,053,184
+201,809
| +11% | +$6.59M | 0.08% | 285 |
|
|
2015
Q4 | $69.1M | Buy |
1,851,375
+392,587
| +27% | +$14.8M | 0.08% | 270 |
|
|
2015
Q3 | $55.4M | Buy |
1,458,788
+813,863
| +126% | +$28.6M | 0.06% | 340 |
|
|
2015
Q2 | $18.4M | Buy |
644,925
+621,827
| +2,692% | +$17.3M | 0.02% | 741 |
|
|
2015
Q1 | $647K | Buy |
23,098
+2,500
| +12% | +$70.2K | ﹤0.01% | 1831 |
|
|
2014
Q4 | $570K | Hold |
20,598
| – | – | ﹤0.01% | 1873 |
|
|
2014
Q3 | $460K | Buy |
20,598
+1,800
| +10% | +$45.7K | ﹤0.01% | 1931 |
|
|
2014
Q2 | $546K | Hold |
18,798
| – | – | ﹤0.01% | 1868 |
|
|
2014
Q1 | $534K | Buy |
18,798
+700
| +4% | +$23.2K | ﹤0.01% | 1850 |
|
|
2013
Q4 | $699K | Sell |
18,098
-1,100
| -6% | -$39.3K | ﹤0.01% | 1648 |
|
|
2013
Q3 | $644K | Buy |
19,198
+500
| +3% | +$15.9K | ﹤0.01% | 1668 |
|
|
2013
Q2 | $575K | Buy |
+18,698
| New | +$626K | ﹤0.01% | 1647 |
|
Other funds holding MDCO
UBS AM's MDCO Position: Q1 2020 in Review
UBS AM sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 232,815 shares — an estimated $19.8M sold.
UBS AM first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $69.1M in Q4 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- UBS AM reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- UBS AM sold 232,815 Medicines Co shares in Q1 2020, an estimated $19.8M.
- UBS AM first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- UBS AM's Medicines Co position peaked at $69.1M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on UBS AM's 13F filing for Q1 2020, filed 15 May 2020.